Cargando…

Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions

SIMPLE SUMMARY: Uterine sarcomas are the second most common unexpected malignancy diagnosed after surgery. It is worrisome, as its preoperative diagnosing can impact the choice of the treatment method, including surgery. Therefore, nowadays, many researchers are trying to find innovative methods to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Żak, Klaudia, Zaremba, Bartłomiej, Rajtak, Alicja, Kotarski, Jan, Amant, Frédéric, Bobiński, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029111/ https://www.ncbi.nlm.nih.gov/pubmed/35454875 http://dx.doi.org/10.3390/cancers14081966

Ejemplares similares

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma
por: Suh, Dong Soo, et al.
Publicado: (2021)

Preoperative Diagnosis of Usual Leiomyoma, Atypical Leiomyoma, and Leiomyosarcoma
por: Matsuda, M., et al.
Publicado: (2014)

Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
por: Rajtak, Alicja, et al.
Publicado: (2022)

Diagnosis of Leiomyosarcoma after Uterine Artery Embolization for Multiple Leiomyomas
por: Tsuji, Maako, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio (NLR) for Preoperative Differentiation between Uterine Leiomyosarcoma (LMS) and Uterine Leiomyoma: A Case-Controlled Study
por: Srisutha, Phitsinee, et al.
Publicado: (2023)

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin
por: Amant, Frédéric, et al.
Publicado: (2015)

Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1
por: Okła, Karolina, et al.
Publicado: (2020)

Correction to: Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1
por: Okła, Karolina, et al.
Publicado: (2020)

Developing a Preoperative Algorithm for the Diagnosis of Uterine Leiomyosarcoma
por: Lawlor, Hannah, et al.
Publicado: (2020)

Clinical Relevance of Mortalin in Ovarian Cancer Patients
por: Rajtak, Alicja, et al.
Publicado: (2023)

MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma
por: Bertsch, Elizabeth, et al.
Publicado: (2014)

Two Rare Cases of Uterine Leiomyosarcomas Originating from Submucosal Leiomyomas Proved by Their Immunohistochemistry Profiles
por: Ghorbani, Hossein, et al.
Publicado: (2020)

Diagnostic Performance of MRI to Differentiate Uterine Leiomyosarcoma from Benign Leiomyoma: A Meta-Analysis
por: Virarkar, Mayur, et al.
Publicado: (2020)

Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
por: De Wispelaere, Wout, et al.
Publicado: (2021)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas
por: Barker, K T, et al.
Publicado: (2002)

FDG-PET/CT findings of atypical (bizarre/symplastic) uterine leiomyoma in a patient with abdominal leiomyosarcoma
por: Hubelé, Fabrice, et al.
Publicado: (2015)

Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma
por: Machado-Lopez, Alba, et al.
Publicado: (2022)

MR Imaging of a Leiomyosarcoma Arising in Leiomyoma
por: Fujii, Shinya, et al.
Publicado: (2018)

Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma
por: Yokoi, Akira, et al.
Publicado: (2019)

Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q
por: Holzmann, Carsten, et al.
Publicado: (2018)

DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma
por: Ke, Yumin, et al.
Publicado: (2022)

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
por: Maia Falcão, Raul, et al.
Publicado: (2022)

Bladder leiomyoma presenting as uterine pedunculated leiomyoma
por: Nazari, Zeinab, et al.
Publicado: (2022)

Prognostic significance of preoperative (18)F-FDG PET/CT in uterine leiomyosarcoma
por: Park, Jeong-Yeol, et al.
Publicado: (2017)

Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
por: Zhang, Guorui, et al.
Publicado: (2020)

Uterine leiomyoma with tubules
por: Pusiol, Teresa, et al.
Publicado: (2008)

Uterine Leiomyomas: An ENIGMA
por: Geethamala, Kempula, et al.
Publicado: (2016)

Ultrasonography of uterine leiomyomas
por: Woźniak, Andrzej, et al.
Publicado: (2017)

Pathological findings of uterine tumors preoperatively diagnosed as red degeneration of leiomyoma by MRI
por: Nakai, Go, et al.
Publicado: (2017)

Pulmonary Benign Metastasizing Leiomyoma from the Uterine Leiomyoma: A Case Report
por: Kołaczyk, Katarzyna, et al.
Publicado: (2015)

Pulmonary benign metastasizing leiomyoma from uterine leiomyoma
por: Chen, Sufeng, et al.
Publicado: (2013)

Primary Ovarian Leiomyoma Associated with Multiple Uterine Leiomyomas
por: Kitamura, Yoshihiro, et al.
Publicado: (2021)

Case report: Atypical, ‘symplastic’ leiomyoma recurring as leiomyosarcoma in the vagina()()
por: Cooney, Elizabeth J., et al.
Publicado: (2015)

microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells
por: Pan, Qun, et al.
Publicado: (2010)

Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels
por: Miyata, Tomoko, et al.
Publicado: (2015)

Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas
por: Conconi, Donatella, et al.
Publicado: (2021)

Massive Uterine Leiomyoma in a Patient with Friedreich's Ataxia: Is There a Possible Association?
por: Misiakos, Evangelos P., et al.
Publicado: (2011)

Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma
por: Tanioka, Saki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kqu0bm364rp22705ch375domrc